MSC for Occlusive Disease of the Kidney
Completed · Phase 1
Conditions studied: Atherosclerotic Renal Artery Stenosis, Ischemic Nephropathy, Renovascular Hypertension
In brief
To determine the safety and toxicity of intra-arterial infused autologous adipose derived mesenchymal stromal (stem) cells in patients with vascular occlusive disease of the kidney.
Key facts
- Study ID
- NCT01840540
- Run by
- Mayo Clinic
- People needed
- 6
- Starts
- 2013-04-01
- Expected to finish
- 2017-04-01
- Last updated by the study team
- 2017-08-07
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.